Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

A Randomized Trial on the Safety and Efficacy of Early Start of Iron Chelation Therapy with Deferiprone in Newly Diagnosed Children with Transfusion Dependent Thalassemia

Mohsen Saleh Elalfy, MD, Vasilios Berdoukas, MB, BS, Fernando Tricta, MD, Amira Adly, Nyeria Hazza, Hanem Awed, Basma Helal, Mohamed Tarif Salam

Blood (2016) 128 (22): 1286.

https://doi.org/10.1182/blood.V128.22.1286.1286

Published: 2016

Journal Articles

Cardiac Iron Overload In Sickle-Cell Disease

Antonella Meloni, PhD, Mammen Puliyel, M.B., B.S., Alessia Pepe, MD, PhD, Massimo Lombardi, MD, Vasilios Berdoukas, MB, BS, Thomas D. Coates, MD, John C Wood, MD, PhD

Blood (2013) 122 (21): 1013.

https://doi.org/10.1182/blood.V122.21.1013.1013

Published: 2013

Journal Articles

Glucose Phosphate Isomerase Deficiency In 2 Patients With Novel Mutations Presenting As Severe Neurologic Abnormalities and Transfusion Dependent Hemolytic Anemia

Mammen Puliyel, M.B., B.S., Patrick G. Gallagher, MD, Vasilios Berdoukas, MBBS, Bertil Glader, MD, PhD, Thomas Coates, MD

Blood (2013) 122 (21): 947.

https://doi.org/10.1182/blood.V122.21.947.947

Published: 2013

Journal Articles

Changes in Regional Oxygenation At the Site of Sickle Cell Vaso-Occlusive Pain

Roberta Miyeko Kato, MD, Anne Nord, RN, BSN, CCRP, Erin McGuire, BS, Daniel Gardner, Adam M Bush, BS, Jon Detterich, MD, Michael Khoo, PhD, Herbert J Meiselman, ScD, John C Wood, MD, Ph.D, Vasilios Berdoukas, MBBS, Thomas D. Coates, MD

Blood (2012) 120 (21): 4773.

https://doi.org/10.1182/blood.V120.21.4773.4773

Published: 2012

Journal Articles

Changes in Pituitary Iron, Volume, and Function Over Two Years in Pediatric Patients Treated with Deferasirox

John C Wood, MD, Ph.D, Leila Noetzli, BS, Ashok Panigrahy, MD, Carole Paley, MD, Ani Dongelyan, BA, Tatiana Hernandez, BA, CCRP, Vasilios Berdoukas, MB, BS, Thomas D. Coates, MD

Blood (2012) 120 (21): 3206.

https://doi.org/10.1182/blood.V120.21.3206.3206

Published: 2012

Journal Articles

Evaluating Toxic Free Iron and Options for Keeping It At Bay in Iron Overloaded Patients.

Farmaki Kallistheni, MD, Vasilios Berdoukas, MB, BS, Giorgos Chouliaras, MD, Christina Pappa, MD, Zvi Ioav Cabantchik, MD, PhD, Ioanna Tzoumari, MD

Blood (2012) 120 (21): 2110.

https://doi.org/10.1182/blood.V120.21.2110.2110

Published: 2012

Journal Articles

Cardiac Iron Overload Causes Clinically Evident Heart Failure and Arrhythmia in Sickle Cell Anemia Patients: Evidence From Three Cases

Bhakti P. Mehta, MBBS, Vasilios Berdoukas, MB, BS, Mammen Puliyel, M.B., B.S., Adam Bush, BS, Thomas Hofstra, MD, Susan Claster, MD, Anne Nord, RN, BSN, CCRP, Susan Carson, RN, CPNP, MSN, Tatiana Hernandez, BA, CCRP, Ani Dongelyan, BA, John C Wood, MD, Ph.D, Thomas D. Coates, MD

Blood (2011) 118 (21): 4846.

https://doi.org/10.1182/blood.V118.21.4846.4846

Published: 2011

Journal Articles

Trends in Ferritin Can Be Dramatically Different From Trends in Total Body Iron and Could Lead to Erroneous Decisions in Iron Chelation Management and Discourage Adherence in Chronically Transfused Patients,

Mammen Puliyel, M.B., B.S., Adam Bush, BS, Vasilios Berdoukas, MB, BS, Thomas Hofstra, MD, Susan Claster, MD, Bhakti P. Mehta, MBBS, Anne Nord, RN, BSN, CCRP, Susan Carson, RN, CPNP, MSN, Tatiana Hernandez, BA, CCRP, Ani Dongelyan, BA, John C Wood, MD, Ph.D, Thomas D. Coates, MD

Blood (2011) 118 (21): 3203.

https://doi.org/10.1182/blood.V118.21.3203.3203

Published: 2011

Journal Articles

Liver and Cardiac Iron Measurements in Very Young Chronically Transfused Patients Show Dangerous Levels of Iron Loading

Vasilios Berdoukas, MB, BS, Mammen Puliyel, M.B., B.S., Adam Bush, BS, Thomas Hofstra, MD, Bhakti P. Mehta, MBBS, Anne Nord, RN, BSN, CCRP, Susan Carson, RN, CPNP, MSN, Tatiana Hernandez, BA, CCRP, Ani Dongelyan, BA, John C Wood, MD, Ph.D, Thomas D. Coates, MD

Blood (2011) 118 (21): 1086.

https://doi.org/10.1182/blood.V118.21.1086.1086

Published: 2011

Journal Articles

Combination of Two Orally Active Iron Chelating Agents: Efficacy and Safety In a Clinical Setting

Vasilios Berdoukas, MBBS, Susan Carson, RN, MSN, CPNP, Anne Nord, RN, BSN, CCRP, Thomas Hofstra, MD, Susan Claster, MD, John Wood, MD, PhD, Thomas D. Coates, MD

Blood (2010) 116 (21): 2064.

https://doi.org/10.1182/blood.V116.21.2064.2064

Published: 2010

Journal Articles

Prevelance of Cardiac Dysfunction in Patients with Thalassemia Major with Respect to Cardiac Magnetic Resonance.

Antonios Kattamis, Vasilios Berdoukas, MB, BS, Eleni Berdoussi, Kirikos Zannikos, Vassilios Ladis

Blood (2009) 114 (22): 2013.

https://doi.org/10.1182/blood.V114.22.2013.2013

Published: 2009

Journal Articles

Long-Term Effects of Combined Chelation Therapy on Glucose Metabolism of Thalassemic Patients.

Kalistheni Farmaki, Nicholas Angelopoulos, Vasilios Berdoukas, Ioanna Tsoumari, Christina Pappa, Kiki Pappagianni

Blood (2007) 110 (11): 2770.

https://doi.org/10.1182/blood.V110.11.2770.2770

Published: 2007

Journal Articles

Reversal of Complications Following Intensive Combined Chelation in β-Thalassemia Major Patients.

Kallistheni Farmaki, MD, Ioanna Tzoumari, MD, Christina Pappa, MD, Christos Tompoukis, MD, Aggeliki Papagianni, MD, Nikos Aggelopoulos, MD, Demetrios Mitas, MD, Vasilios Berdoukas, MB, BS

Blood (2007) 110 (11): LB4.

https://doi.org/10.1182/blood.V110.11.LB4.lb4

Published: 2007

NARROW

A Randomized Trial on the Safety and Efficacy of Early Start of Iron Chelation Therapy with Deferiprone in Newly Diagnosed Children with Transfusion Dependent Thalassemia

Cardiac Iron Overload In Sickle-Cell Disease

Glucose Phosphate Isomerase Deficiency In 2 Patients With Novel Mutations Presenting As Severe Neurologic Abnormalities and Transfusion Dependent Hemolytic Anemia

Changes in Regional Oxygenation At the Site of Sickle Cell Vaso-Occlusive Pain

Changes in Pituitary Iron, Volume, and Function Over Two Years in Pediatric Patients Treated with Deferasirox

Evaluating Toxic Free Iron and Options for Keeping It At Bay in Iron Overloaded Patients.

Cardiac Iron Overload Causes Clinically Evident Heart Failure and Arrhythmia in Sickle Cell Anemia Patients: Evidence From Three Cases

Trends in Ferritin Can Be Dramatically Different From Trends in Total Body Iron and Could Lead to Erroneous Decisions in Iron Chelation Management and Discourage Adherence in Chronically Transfused Patients,

Liver and Cardiac Iron Measurements in Very Young Chronically Transfused Patients Show Dangerous Levels of Iron Loading

Combination of Two Orally Active Iron Chelating Agents: Efficacy and Safety In a Clinical Setting

Prevelance of Cardiac Dysfunction in Patients with Thalassemia Major with Respect to Cardiac Magnetic Resonance.

Long-Term Effects of Combined Chelation Therapy on Glucose Metabolism of Thalassemic Patients.

Reversal of Complications Following Intensive Combined Chelation in β-Thalassemia Major Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only